KR920011492A - Injectable composition of siflofloxacin and preparation method thereof - Google Patents

Injectable composition of siflofloxacin and preparation method thereof Download PDF

Info

Publication number
KR920011492A
KR920011492A KR1019900020148A KR900020148A KR920011492A KR 920011492 A KR920011492 A KR 920011492A KR 1019900020148 A KR1019900020148 A KR 1019900020148A KR 900020148 A KR900020148 A KR 900020148A KR 920011492 A KR920011492 A KR 920011492A
Authority
KR
South Korea
Prior art keywords
acetyl
injectable composition
valine
alanine
acids
Prior art date
Application number
KR1019900020148A
Other languages
Korean (ko)
Other versions
KR930001302B1 (en
Inventor
이한구
이우영
Original Assignee
이성훈
주식회사 중외제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이성훈, 주식회사 중외제약 filed Critical 이성훈
Priority to KR1019900020148A priority Critical patent/KR930001302B1/en
Publication of KR920011492A publication Critical patent/KR920011492A/en
Application granted granted Critical
Publication of KR930001302B1 publication Critical patent/KR930001302B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음No content

Description

시플로플록사신의 주사용 조성물 및 그 제조방법Injectable composition of siflofloxacin and preparation method thereof

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (6)

활성화합물(Ⅰ)을 제제보조제와 함께 물에 주입하고 N-아세틸 아미노산류를 가하여 제조된 활성 화합물(Ⅰ)의 화합물의 N-아세틸 아미노산류염류를 함유하는 주사용 조성물.An injectable composition containing N-acetyl amino acid salts of a compound of the active compound (I) prepared by injecting the active compound (I) with water to the preparation aid and adding N-acetyl amino acids. 제1항에서 N-아세틸아미노산류로서 N-아세틸-L-타이로신, N-아세틸-L-시스테인, N-아세틸-DL-알라닌, N-아세틸-DL-발린, N-아세틸-DL-글라이신, N-아세틸-DL-메티오닌, N-아세틸-L-알라닌 및 N-아세틸-L-발린에서 선택된 N-아세틸아미노산류를 함유한 주사용 조성물.N-acetyl-L-tyrosine, N-acetyl-L-cysteine, N-acetyl-DL-alanine, N-acetyl-DL-valine, N-acetyl-DL-glycine as claimed in claim 1, An injectable composition containing N-acetylamino acids selected from N-acetyl-DL-methionine, N-acetyl-L-alanine and N-acetyl-L-valine. 제1항에 있어서, 용액 중 N-아세틸 아미노산 함량이 0. 1 내지 10%임을 특징으로 하는 주사용 조성물.The injectable composition of claim 1 wherein the N-acetyl amino acid content in the solution is from 0.1 to 10%. 활성화합물(Ⅰ)을 제제보조제와 함께 물에 주입하고 N-아세틸 아미노산류를 가하여 활성화합물(Ⅰ)의 N-아세틸 아미노산류를 함유하는 주사용 조성물을 제조하는 방법.A method of preparing an injectable composition containing N-acetyl amino acids of the active compound (I) by injecting the active compound (I) with water to the preparation aid and adding N-acetyl amino acids. 제4항에서 N-아세틸아미노산류로서 N-아세틸-L-타이로신, N-아세틸-N-시스테인, N-아세틸-L-알라닌, N-아세틸-DL-발린, N-아세틸-DL-글리신, N-아세틸-DL-메치오닌, N-아세틸-N-알라닌 및 N-아세틸-N-발린에서 선택된 N-아세틸아미노산류를 사용하는 방법.N-acetyl-acids as N-acetylamino acids, N-acetyl-N-cysteine, N-acetyl-L-alanine, N-acetyl-DL-valine, N-acetyl-DL-glycine, A method of using N-acetylamino acids selected from N-acetyl-DL-methionine, N-acetyl-N-alanine and N-acetyl-N-valine. 제4항에서 N-아세틸아미노산의 함량이 0.1 내지 10%임을 특징으로 하는 방법.The method of claim 4, wherein the content of N-acetylamino acid is 0.1 to 10%. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019900020148A 1990-12-07 1990-12-07 Ciprofloxacin injectable composition KR930001302B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019900020148A KR930001302B1 (en) 1990-12-07 1990-12-07 Ciprofloxacin injectable composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900020148A KR930001302B1 (en) 1990-12-07 1990-12-07 Ciprofloxacin injectable composition

Publications (2)

Publication Number Publication Date
KR920011492A true KR920011492A (en) 1992-07-24
KR930001302B1 KR930001302B1 (en) 1993-02-25

Family

ID=19307218

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900020148A KR930001302B1 (en) 1990-12-07 1990-12-07 Ciprofloxacin injectable composition

Country Status (1)

Country Link
KR (1) KR930001302B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010642A1 (en) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Drug formulations containing fluoroquinolones
CN102697725B (en) * 2012-06-07 2013-06-12 山东省健牧生物药业有限公司 Veterinary ciprofloxacin lactate injection and preparation method thereof

Also Published As

Publication number Publication date
KR930001302B1 (en) 1993-02-25

Similar Documents

Publication Publication Date Title
KR840005083A (en) Method for preparing amino acid derivatives useful as antihypertensive agents
KR860003013A (en) Method of Preparation of Stabilized Pyroxycam Injectable Solution
KR850006135A (en) Ophthalmic solution
KR860002268A (en) Method for preparing skin nutrient
FI845004A0 (en) MUNSKOELJNINGSLOESNING.
KR880001282A (en) Oxazaphosphorin solution and preparation method thereof
KR920011492A (en) Injectable composition of siflofloxacin and preparation method thereof
KR870001269A (en) Aqueous liquid reactive dye compositions
KR850000468A (en) Method for preparing cyclic peptide
KR870003097A (en) (+)-6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl) acetyl] -11H-dibenzo [b, e] [1,4] diazepine-11 Separation method
KR890005195A (en) Blocked Acid Catalyst
KR860002269A (en) Process for preparing parenteral solutions
KR910000154A (en) Stabilized Pyroxycam Injection Composition and Preparation Method Thereof
KR890011901A (en) Animal growth promoters
KR920005894A (en) Liquid Seasoned Concentrate
BR8602609A (en) PROCESS FOR THE PREPARATION OF A WATER SOLUTION OF A HETEROPOLYSACARIDE, A WATER SOLUTION OF A HETEROPOLYSACARIDE, AND PROCESS FOR USING A WATER SOLUTION OF A HETEROPOLYSACARIDE
KR840009032A (en) Oxytetracycline aqueous solution for animal injection and its manufacturing method
KR830002778A (en) Crystallization method
KR860003011A (en) Water-soluble pharmaceutical composition containing a salt of (-) cis-1,2-epoxypropylphosphonic acid and amino acid
KR900016226A (en) Method for preparing celldidium sodium
KR870002051A (en) Process for preparing L-phenylalanine ester
KR860000822A (en) Method for preparing calcium lactate and amino acid solution from corn steep liquor
KR860002234A (en) Sterilization of foods using fatty acids
KR830003875A (en) How to control marine organisms
KR830007646A (en) Degradation of trans-5-aryl-2, 3, 4,4a-5,9b-hexahydro-1H-pyrido [4 3-b] indole

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19980224

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee